Recent study has reported that GM-CSF–expressing T cells were enriched in the joints of sJIA patients, highlighting the potential role of Th17-related cytokines in the pathology of sJIA [40]. The gene discussed is CSF2; the disease is systemic-onset juvenile idiopathic arthritis.